CN105901714A - Euglena compound tablet and preparation method thereof - Google Patents
Euglena compound tablet and preparation method thereof Download PDFInfo
- Publication number
- CN105901714A CN105901714A CN201610267877.6A CN201610267877A CN105901714A CN 105901714 A CN105901714 A CN 105901714A CN 201610267877 A CN201610267877 A CN 201610267877A CN 105901714 A CN105901714 A CN 105901714A
- Authority
- CN
- China
- Prior art keywords
- euglena
- powder
- chlorella
- magnesium stearate
- silicon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195620 Euglena Species 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000000843 powder Substances 0.000 claims abstract description 45
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 36
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 31
- 235000020712 soy bean extract Nutrition 0.000 claims abstract description 21
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 19
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 18
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 17
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 17
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 17
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 235000012239 silicon dioxide Nutrition 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 11
- 239000000385 dialysis solution Substances 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 8
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 8
- 235000008696 isoflavones Nutrition 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000004695 Polyether sulfone Substances 0.000 claims description 3
- 235000019764 Soybean Meal Nutrition 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229920006393 polyether sulfone Polymers 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000004455 soybean meal Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229940069765 bean extract Drugs 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 235000010980 cellulose Nutrition 0.000 abstract description 2
- 229920002678 cellulose Polymers 0.000 abstract description 2
- 239000001913 cellulose Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000009702 cancer cell proliferation Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000005727 virus proliferation Effects 0.000 abstract 1
- 238000007907 direct compression Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- -1 bioflavonoids Chemical compound 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an euglena compound tablet and a preparation method thereof. The euglena compound tablet contains 40-90% of euglena powder, 5-35% of chlorella powder, 1-20% of soybean extract, 0.1-5% of microcrystalline cellulose, 0.2-5% of silica and 0.5-5% of magnesium stearate. The preparation method includes: selecting the euglena powder, the chlorella powder and the soybean extract as main materials; subjecting the main materials to smashing, sieving, mixing and sterilizing; combining with magnesium stearate, cellulose and silica which are auxiliary materials; performing fine processing. The euglena compound tablet can quickly balance and replenish nutrition, enhance body immunity and improve and protect human blood circulating system, and has functions of improving the body immunity, preventing virus proliferation, inhibiting cancer cell proliferation and blood sugar rise, lowering serum cholesterol content, removing toxin and quickly restoring body damage; types of the auxiliary materials added are few, and the production process is simple to operate.
Description
Technical field
The invention belongs to health food preparing technical field, particularly relate to a kind of Euglena complex tablet and preparation method thereof.
Background technology
Euglena photosynthesis is strong, containing abundant nutrition composition: the nutrient that vitamin, mineral nutrition thing, aminoacid, unsaturated fatty acid, chlorophyll, lutein, cryptoxanthin, GABA etc. 59 kinds human body every day is required, is all to maintain healthy indispensable nutrient.The Euglena polysaccharide component that Euglena contains; the activity of internal useful enzyme is promoted while removing the unnecessary materials such as bad cholesterol, neutral fat, heavy metal; adjust the intestines and stomach, the liver protecting, purification blood; allergic dermatitis is also had abirritation, is applied in the medicine of constipation, stool, acquired immune deficiency syndrome (AIDS) etc. and preventing and treating allergic symptom.Chlorella cells is contained within the chlorophyll enriched, and belongs to monoplast green alga, is eukaryote.There is enhancing human immunity, prevent virus multiplication, anticancer propagation, suppression blood glucose from rising, reduce serum cholesterol content, get rid of toxin, repair rapidly the function such as damage of body.
The medicine for improving and protect blood circulation of human body system, delaying senility function that prior art provides, effect is notable, and interpolation supplementary product kind is many, ratio big, production technology operation complexity, produces and use cost is higher.
Summary of the invention
The invention provides a kind of Euglena complex tablet and preparation method thereof; aim to solve the problem that the medicine for improving and protect blood circulation of human body system, delaying senility function that prior art provides; effect is the most notable; and add supplementary product kind is many, ratio is big; the problem that production technology operation complexity, production and use cost are higher.
The concrete technical scheme of the present invention is as follows:
A kind of Euglena complex tablet, this Euglena complex tablet includes the raw material of following percentage by weight
: the Euglena powder of 40-90%, the chlorella powder of 5-35%, the soybean extract of 1-20%, the microcrystalline Cellulose of 0.1-5%, the silicon dioxide of 0.2-5%, the magnesium stearate of 0.5-5%.
Described chlorella powder is that fresh chlorella obtains through being spray-dried to be dried, and in chlorella powder, protein content is more than the 60% of dry weight, is wherein spray-dried pressure characteristic and is that atomizing pressure is 4-5Kg/cm2。
Described soybean extract is that Semen sojae atricolor is soaking, extracts, concentrates, separates, is dried acquisition, and Isoflavone in Extract of Soybean content is 40%, and described method comprises the following steps:
(1) prepare extracting solution: with defatted soybean meal as raw material, with the ethanol solution that volumetric concentration is 70% under the conditions of 50 ~ 70 DEG C, filter with the filter press of four metafiltration paper after extracting 6 ~ 10h, it is thus achieved that extracting solution；
(2) dialysis solution is prepared: by the extracting solution polyether sulfone organic ultrafilter membrane ultrafiltration described in step (1)；Ultrafilter membrane aperture is 2500 ~ 1000 OD, ultrafiltration pressure 2.0～11.0bar, feed liquid flow 4.0 ~ 12.0L/min, feed temperature 11 ~ 50 DEG C；Tracing detection dialysate flow in ultra-filtration process, shuts down when dialysate flow drastically declines, and collects dialysis solution；
(3) to upper step gained dialysis solution concentrate drying, described soybean isoflavone is obtained.
The present invention also provides for a kind of method preparing above-mentioned Euglena complex tablet, and step is as follows: step one, Euglena, chlorella powder, soybean extract, microcrystalline Cellulose, silicon dioxide, magnesium stearate is pulverized respectively, mistake
40-60 mesh sieve, standby；
Step 2, the Euglena powder after pulverizing, sieve in proportion, chlorella powder, soybean extract, microcrystalline Cellulose, silicon dioxide, magnesium stearate are sufficiently mixed, and are directly compressed into complex tablet after crossing 40-60 mesh sieve.
Described each raw material weight percentage ratio is as follows: the Euglena powder of 40-90%, the chlorella powder of 5-35%, the soybean extract of 1-20%, the microcrystalline Cellulose of 0.1-5%, the silicon dioxide of 0.2-5%, the magnesium stearate of 0.5-5%.
First by Euglena powder, chlorella powder, after soybean extract mixing is sieved, add microcrystalline Cellulose, silicon dioxide, magnesium stearate, after being sufficiently mixed uniformly, cross 40-60 eye mesh screen.
This Euglena complex tablet selects Euglena powder, chlorella powder and soybean extract to be major ingredient, size-reduced, sieve, mix, after sterilization treatment, then be equipped with adjuvant magnesium stearate, cellulose and silicon dioxide, and retrofit forms；
Euglena complex tablet prepared by the present invention, raw material based on Euglena powder, adds chlorella powder, soybean extract, through scientific compatibility, retrofit forms, integrating nutrition and function, three's concertedness strengthens, and effect is notable, and add supplementary product kind is few, ratio is little, in technique simple to operate, use dry powder direct tabletting form, it is easy to control tablet quality.
Euglena complex tablet prepared by the present invention not only maintains Euglena nutrition but also enhance chlorella protein and soybean isoflavone functional component, rich in abundant high quality protein and eight kinds of aminoacid of needed by human, multivitamin, γ-linolenic acid, β-carotene, polysaccharide, flavonoid, bioflavonoids, isoflavone isoreactivity material.
Detailed description of the invention
Euglena complex tablet prepared by the present invention every 0.5-3.0 gram, containing chlorella powder, soybean extract and Euglena fine powder 0.495-2.985 gram, containing microcrystalline Cellulose, silicon dioxide and magnesium stearate 0.005-0.015 gram.
Embodiment one:
Taking 400 grams of Euglena powder, chlorella powder 50 grams, soybean extract 10 grams is primary raw material, and mixing is sieved, then is equipped with microcrystalline Cellulose 1 gram, silicon dioxide 2 grams, magnesium stearate 5 grams, after being sufficiently mixed uniformly, crosses 40-60 eye mesh screen, and direct compression forms；Prepared weight is the complex tablet of 0.5 gram/piece.
Embodiment two:
Taking 400 grams of Euglena powder, chlorella powder 50 grams, soybean extract 10 grams is primary raw material, and mixing is sieved, then is equipped with microcrystalline Cellulose 1 gram, silicon dioxide 2 grams, magnesium stearate 5 grams, after being sufficiently mixed uniformly, crosses 40-60 eye mesh screen, and direct compression forms；Prepared weight is the complex tablet of 3.0 grams/piece.
Embodiment three:
Taking 900 grams of Euglena powder, chlorella powder 350 grams, soybean extract 200 grams is primary raw material, and mixing is sieved, then is equipped with microcrystalline Cellulose 50 grams, silicon dioxide 50 grams, magnesium stearate 50 grams, after being sufficiently mixed uniformly, crosses 40-60 eye mesh screen, and direct compression forms；Prepared weight is the complex tablet of 0.5 gram/piece.
Embodiment four:
Taking 900 grams of Euglena powder, chlorella powder 350 grams, soybean extract 200 grams is primary raw material, and mixing is sieved, then is equipped with microcrystalline Cellulose 50 grams, silicon dioxide 50 grams, magnesium stearate 50 grams, after being sufficiently mixed uniformly, crosses 40-60 eye mesh screen, and direct compression forms；Prepared weight is the complex tablet of 3.0 grams/piece.
In above-described embodiment
Chlorella powder is that fresh chlorella obtains through being spray-dried to be dried, and in chlorella powder, protein content is more than the 60% of dry weight, is wherein spray-dried pressure characteristic and is that atomizing pressure is 4-5Kg/c.
Soybean extract is that Semen sojae atricolor is soaking, extracts, concentrates, separates, is dried acquisition, and Isoflavone in Extract of Soybean content is 40%, and described method comprises the following steps:
(1) prepare extracting solution: with defatted soybean meal as raw material, with the ethanol solution that volumetric concentration is 70% under the conditions of 50 ~ 70 DEG C, filter with the filter press of four metafiltration paper after extracting 6 ~ 10h, it is thus achieved that extracting solution；
(2) dialysis solution is prepared: by the organic ultrafilter membrane ultrafiltration of step (1) gained extracting solution polyether sulfone；Ultrafilter membrane aperture is 2500 ~ 1000OD, ultrafiltration pressure 2.0～11.0bar, feed liquid flow 4.0 ~ 12.0L/min, feed temperature 11 ~ 50 DEG C；Tracing detection dialysate flow in ultra-filtration process, shuts down when dialysate flow drastically declines, and collects dialysis solution；
(3) to upper step gained dialysis solution concentrate drying, described soybean isoflavone is obtained.
In above-described embodiment, the blend step of each raw material is: first by Euglena powder, chlorella powder, after soybean extract mixing is sieved, adds microcrystalline Cellulose, silicon dioxide, magnesium stearate, after being sufficiently mixed uniformly, crosses 40-60 eye mesh screen.
Claims (6)
1. an Euglena complex tablet, it is characterised in that: this Euglena complex tablet includes following weight
The Euglena powder of the raw material of percentage ratio: 40-90%, the chlorella powder of 5-35%, 1-20% big
Bean extract, the microcrystalline Cellulose of 0.1-5%, the silicon dioxide of 0.2-5%, 0.5-5% hard
Fatty acid magnesium.
2. Euglena complex tablet as claimed in claim 1, it is characterised in that: described chlorella powder
Obtaining through being spray-dried to be dried for fresh chlorella, in chlorella powder, protein content is dry weight
More than 60%, wherein be spray-dried pressure characteristic be that atomizing pressure is 4-5Kg/c.
3. Euglena complex tablet as claimed in claim 1, it is characterised in that: described Semen sojae atricolor is extracted
Thing is that Semen sojae atricolor is soaking, extracts, concentrates, separates, is dried acquisition, Semen sojae atricolor in soybean extract
Isoflavone content is 40%, and described method comprises the following steps:
(1) extracting solution is prepared: with defatted soybean meal as raw material, molten with the ethanol that volumetric concentration is 70%
Liquid, under the conditions of 50～70 DEG C, extracts and filters with the filter press of four metafiltration paper after 6～10h,
Obtain extracting solution；
(2) dialysis solution is prepared: by the organic ultrafilter membrane ultrafiltration of step (1) gained extracting solution polyether sulfone；
Ultrafilter membrane aperture is 2500～1000OD, ultrafiltration pressure 2.0～11.0bar, feed liquid flow
4.0～12.0L/min, feed temperature 11～50 DEG C；Tracing detection dialysate flow in ultra-filtration process,
Shut down when dialysate flow drastically declines, collect dialysis solution；
(3) to upper step gained dialysis solution concentrate drying, described soybean isoflavone is obtained.
4. the method preparing Euglena complex tablet as claimed in claim 1, it is characterised in that:
Step is as follows: step one, by Euglena, chlorella powder, soybean extract, microcrystalline Cellulose,
Silicon dioxide, magnesium stearate are pulverized respectively, cross 40-60 mesh sieve, standby；
Step 2, in proportion will pulverize, sieve after Euglena powder, chlorella powder, soybean extract,
Microcrystalline Cellulose, silicon dioxide, magnesium stearate are sufficiently mixed, and directly press after crossing 40-60 mesh sieve
Make complex tablet.
5. preparation method as claimed in claim 4, it is characterised in that: described each raw material weight hundred
Proportion by subtraction is as follows: the Euglena powder of 40-90%, the chlorella powder of 5-35%, the Semen sojae atricolor of 1-20% are extracted
Thing, the microcrystalline Cellulose of 0.1-5%, the silicon dioxide of 0.2-5%, the magnesium stearate of 0.5-5%.
6. preparation method as claimed in claim 4, it is characterised in that: the mixing of described step 2
Step is: first by Euglena powder, chlorella powder, after soybean extract mixing is sieved, adds micro-
Crystalline cellulose, silicon dioxide, magnesium stearate, after being sufficiently mixed uniformly, cross 40-60 mesh
Screen cloth.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610267877.6A CN105901714A (en) | 2016-04-27 | 2016-04-27 | Euglena compound tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610267877.6A CN105901714A (en) | 2016-04-27 | 2016-04-27 | Euglena compound tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105901714A true CN105901714A (en) | 2016-08-31 |
Family
ID=56752965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610267877.6A Pending CN105901714A (en) | 2016-04-27 | 2016-04-27 | Euglena compound tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105901714A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108697741A (en) * | 2016-03-04 | 2018-10-23 | 悠绿那股份有限公司 | Antivirotic and antiviral use food |
| CN112089057A (en) * | 2019-06-18 | 2020-12-18 | 安琪酵母股份有限公司 | Composition containing naked algae powder and yeast powder, preparation method and application |
| WO2023243856A1 (en) * | 2022-06-14 | 2023-12-21 | 경희대학교 산학협력단 | Composition for preventing, ameliorating or treating blood dyscrasia comprising microorganism of genus euglena |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102424674A (en) * | 2011-10-27 | 2012-04-25 | 浙江工业大学 | Method for extracting soybean isoflavone extract |
| CN103211843A (en) * | 2013-04-16 | 2013-07-24 | 甘肃凯源生物技术开发中心 | Formula and preparation method of algae tablet |
| CN103284165A (en) * | 2013-06-17 | 2013-09-11 | 宋信宇 | Applications of algae in solid beverage and formulae |
| CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
| CN104522827A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment nutritional solid drink and preparation process thereof |
| CN104605340A (en) * | 2014-12-10 | 2015-05-13 | 黑龙江众生生物工程有限公司 | Euglena oral liquid and production method thereof |
-
2016
- 2016-04-27 CN CN201610267877.6A patent/CN105901714A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102424674A (en) * | 2011-10-27 | 2012-04-25 | 浙江工业大学 | Method for extracting soybean isoflavone extract |
| CN103211843A (en) * | 2013-04-16 | 2013-07-24 | 甘肃凯源生物技术开发中心 | Formula and preparation method of algae tablet |
| CN103284165A (en) * | 2013-06-17 | 2013-09-11 | 宋信宇 | Applications of algae in solid beverage and formulae |
| CN104605340A (en) * | 2014-12-10 | 2015-05-13 | 黑龙江众生生物工程有限公司 | Euglena oral liquid and production method thereof |
| CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
| CN104522827A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment nutritional solid drink and preparation process thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108697741A (en) * | 2016-03-04 | 2018-10-23 | 悠绿那股份有限公司 | Antivirotic and antiviral use food |
| CN112089057A (en) * | 2019-06-18 | 2020-12-18 | 安琪酵母股份有限公司 | Composition containing naked algae powder and yeast powder, preparation method and application |
| WO2023243856A1 (en) * | 2022-06-14 | 2023-12-21 | 경희대학교 산학협력단 | Composition for preventing, ameliorating or treating blood dyscrasia comprising microorganism of genus euglena |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105533380B (en) | A kind of Dealcoholic solid beverage and preparation method thereof | |
| CN104706821B (en) | A kind of health-care camellia oil | |
| CN103960717A (en) | Peony plant protein beverage and preparation method thereof | |
| CN106359629B (en) | Method for preparing red bean beverage by using red bean paste bean-boiling wastewater | |
| CN105707270A (en) | Processing technology of walnut polypeptide milk | |
| CN106165896A (en) | A kind of manufacture method of Maca extract | |
| CN105901714A (en) | Euglena compound tablet and preparation method thereof | |
| CN109805155A (en) | A kind of health food of strengthen immunity and preparation method thereof | |
| CN101991165A (en) | Sweet potato leaf-perilla leaf composite beverage and preparation method thereof | |
| CN103168876A (en) | Medlar black tea | |
| CN105996028A (en) | Ginger extract, ginger fiber and preparation method of ginger extract and ginger fiber | |
| CN105029408A (en) | Dendrobium officinale and gynostemma pentaphylla capsule and preparation method thereof | |
| CN104293555B (en) | A kind of black garlic grape wine and production method thereof | |
| CN104382127B (en) | A kind of black Bulbus Allii honey vinegar beverage | |
| CN104544430A (en) | Compound honeysuckle plant beverage | |
| CN107494769B (en) | Grape seed blend oil and preparation method thereof | |
| CN102423070A (en) | Natto capsule and its preparation method | |
| CN105192244A (en) | Method for preparing snakegourd fruit seed polypeptides | |
| CN103937597A (en) | Heat clearing and detoxifying peanut oil and its preparation method | |
| CN103431488A (en) | Black garlic-mulberry leaf tea beverage and preparation method thereof | |
| CN112890199A (en) | Composition for stably and efficiently regulating immunologic function and preparation and application thereof | |
| CN103431100A (en) | Asparagus drink with health protection and health maintenance functions | |
| CN102349679A (en) | Jute functional beverage and preparation method thereof | |
| KR20100005920A (en) | Concentrate of turnip root and preparation method thereof | |
| CN105168574A (en) | Healthcare maca oral solution and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160831 |
|
| RJ01 | Rejection of invention patent application after publication |